SLS
Sellas Life Sciences Group, Inc. Health Care Pharmaceutical Preparations Russell 3000
$9.68Close
$1.5BMarket cap
$1.39 – $15.4652-week range
Nov 11, 2026Next report
Highlights
Strengths
- Leading the market RS 99 · stronger than 99% of stocks over 12 months
Cautions
- Not in an uptrend 5 of 8 trend conditions
- Far from its high 37% below its 52-week high
- Distribution down-day volume 1.5× up-day volume over 50 sessions
- Results soon Nov 11, 2026, in 10 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
37%
1wk
down 16.1%
price change
1mo
down 21.4%
price change
12-month return
up 407%
market up 11% ·
its own up 355%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
20.9×
price / book
Earnings yield
down 2.0%
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
down 67%
return on equity
Free cash margin
—
-$28.4M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
10.6%
$1.02 a day · 2×ATR $7.64
RS
99 / 99
vs the universe
Trend
5 / 8
under the 150/200-day, under the 50-day, over 25% off the high
Relative volume
0.9×
vs 50-day average
Up/down volume
0.65
50 sessions
Implied move
—
no option chain · report Nov 11, 2026
Trend template · 5 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 107.0% over the year, from 74m to 153m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 11, 2026
Last shock
Sep 11, 2026-14% in one session2.0× volumeno filing matched-16% since
Financials
- Gross
- Net
- Free cash
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $7.6M | $1.0M | $0 | — | — |
| Gross margin | 100% | 97% | 90% | — | — | — |
| Operating income | -$17.0M | -$25.3M | -$42.0M | -$37.9M | -$31.5M | -$28.3M |
| Net income | -$16.8M | -$20.7M | -$41.3M | -$37.3M | -$30.9M | -$26.9M |
| Net margin | -882% | -272% | -4130% | — | — | — |
| Earnings per share | -$2.10 | -$1.34 | -$2.13 | -$1.34 | -$0.50 | -$0.25 |
| Free cash flow | -$10.4M | -$26.0M | -$23.8M | -$31.4M | -$35.4M | -$28.4M |
| Free cash margin | -548% | -342% | -2381% | — | — | — |
| Cash | $35.3M | $21.4M | $17.1M | $2.5M | $13.9M | $71.8M |
| Shareholders' equity | $28.0M | $20.3M | $4.9M | -$8.0M | $9.5M | $70.9M |
| Shares outstanding | 14.25m | 15.90m | 21.01m | 32.13m | 73.98m | 153.10m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 11, 2026 | Quarterly ↗ | Jun 30, 2026 | 42d |
| May 12, 2026 | Quarterly ↗ | Mar 31, 2026 | 42d |
| Mar 19, 2026 | Annual ↗ | Dec 31, 2025 | 78d |
| Nov 12, 2025 | Quarterly ↗ | Sep 30, 2025 | 43d |
| Aug 12, 2025 | Quarterly ↗ | Jun 30, 2025 | 43d |
| May 13, 2025 | Quarterly ↗ | Mar 31, 2025 | 43d |
| Mar 20, 2025 | Annual ↗ | Dec 31, 2024 | 79d |
| Nov 13, 2024 | Quarterly ↗ | Sep 30, 2024 | 44d |
| Aug 13, 2024 | Quarterly ↗ | Jun 30, 2024 | 44d |
| May 14, 2024 | Quarterly ↗ | Mar 31, 2024 | 44d |
| Mar 28, 2024 | Annual ↗ | Dec 31, 2023 | 88d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 11, 2026 | Results ↗ |
| Jul 27, 2026 | Results · Other events ↗ |
| Jun 25, 2026 | Director or officer change ↗ |
| Jun 18, 2026 | Shareholder vote ↗ |
| Jun 2, 2026 | Other events ↗ |
| May 12, 2026 | Results ↗ |
| Mar 19, 2026 | Results ↗ |
| Mar 11, 2026 | Other events ↗ |
| Jan 8, 2026 | Results · Other events ↗ |
| Nov 12, 2025 | Results ↗ |
| Oct 27, 2025 | Material agreement · Other events ↗ |
| Oct 3, 2025 | Material agreement ↗ |